{"timestamp": 1771602996.1504645, "value": {"ticker": "ALXO", "company_name": "ALX Oncology Holdings Inc.", "short_name": "ALX Oncology Holdings Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 327992768, "float_shares": 12801412, "shares_outstanding": 131197113, "short_ratio": 3.36, "short_percent_of_float": 0.033099998, "shares_short": 1135216, "shares_short_prior": 985188, "insider_percent_held": 0.02898, "institution_percent_held": 0.97540003, "total_cash": 60626000, "total_debt": 15607000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 34.837, "current_ratio": 2.399, "book_value": 0.836, "price_to_book": 2.9904306, "operating_cashflow": -97208000, "free_cashflow": -59847500, "price": 2.5, "52w_high": 2.62, "52w_low": 0.404, "avg_volume": 389693, "avg_volume_10d": 1102370, "full_time_employees": 44, "audit_risk": 0, "overall_risk": 0}}